New York-based virtual care company Teladoc Health announced it has signed a definitive agreement to acquire virtual preventative care company Catapult Health in an all-cash deal worth $65 million.The deal includes an additional $5…
Continue Reading
Cortica, a provider for children with autism and neurodivergent conditions, last week secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures.
San Diego, California-based Cortica offers applied behavior analysis, diagnostic testing,…
Continue Reading
What You Should Know:
– OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participation from Tenacity Ventures, Cedars…
Continue Reading
Introduction
The World Health Organization (WHO) has recently taken a significant step toward mitigating the spread of Mpox by issuing an Emergency Use Listing (EUL) for an in vitro diagnostic test. This test, crucial for…
Women in Somerset with breast lumps will be directly referred to a breast diagnostic clinic via the NHS App under a pilot scheme, health secretary Wes Streeting has announced.
Speaking at the Royal College of…
What You Should Know:
– Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115 billion in cash.
– The acquisition will integrate…
Continue Reading
My Menopause Centre has teamed up with pathology platform Medichecks to provide its patients with access to a range of blood tests to support the appraising of their potential health risks. Since it launched…
Continue Reading
Top News
Walgreens Boots Alliance is struggling with the performance of primary care chain VillageMD, in which it is the majority shareholder.
Walgreens has closed 27 of the 60 underperforming locations that it previously announced and…
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition…
Continue Reading
Boston-based Heranova Lifesciences, a women’s healthcare company focusing on reproductive health, pregnancy and menopause, announced its launch with $13.5 million in seed and seed+ funding.Emerging Technology Partners, Pivotal bioVenture Partners China, Sinovation Ventures and…
Continue Reading
